BUZZ-Dyne Therapeutics 发布 3 亿美元股票发行计划后业绩下滑

路透中文
Dec 10
BUZZ-Dyne <a href="https://laohu8.com/S/LENZ">Therapeutics</a> 发布 3 亿美元股票发行计划后业绩下滑

12月9日 - ** 药物开发商Dyne Therapeutics的DYN.O股价下跌14%至19.09美元

** DYN周一晚些时候启动了 (link),公开发售价值3亿美元的股票。

** 在其肌肉萎缩药物获得积极数据后, (link),周一收盘上涨9.5%。

** 摩根士丹利Morgan Stanley)、杰富瑞(Jefferies)、斯蒂夫尔(Stifel)和古根海姆证券(Guggenheim Securities)是此次发行的联合簿记管理人。

** 募集资金将用于偿还债务和推进产品线开发等用途

** 根据 (link) 的招股说明书,截至 9 月 30 日,DYN 有 1.426 亿股流通股。

** 16家券商中有13家给予该股 "买入 "或更高评级,3家给予 "持有 "评级;PT中值为38美元--数据由LSEG编制

** 截至上次收盘,DYN股价年累计下跌5.8%。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10